| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 533.802 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 396.705 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 373.29 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 631.903 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 438.067 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 384.09 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 365.978 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 562.962 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 490.41 | 91 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 330.859 | 88 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 542.959 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 527.996 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 570.335 | 92 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 442.839 | 91 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 508.251 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 586.238 | 93 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 526.56 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 513.219 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 603.935 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 575.017 | 92 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 540.498 | 92 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 561.364 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 466.582 | 91 |